Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Clinical trial NCT03813940 · COMPLETED

Trial details

NCT number: NCT03813940
Sponsor: Xiamen University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Condylomata Acuminata Cervical Cancer

Start date: 2019-01-03
Primary completion: 2019-08-18
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.